RECRUITING

Use of CGM in Kidney Transplant Recipients

Conditions

Kidney Transplant; Complications Diabetes Mellitus, Type 2 Insulin Dependent Diabetes

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.

Official Title

Continuous Glucose Monitoring (CGM) to Improve Glycemic Control in Kidney Transplant Recipients

Quick Facts

Study Start:2021-06-29

Study Completion:2025-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT04783441

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Age 18 or above 2. Received a kidney transplant within the past year with functioning kidney (eGFR \> 30 mL/min 3. Person with Type 2 Diabetes and on insulin 4. Access to home wi-fi connection	1. Person with Type 1 Diabetes 2. Patients taking hydroxyurea 3. Patient unable to wear the Dexcom G6 device at all times for any reason 4. Must be able to test blood glucose with meter 4x a day when on blinded CGM. 5. Presence of clinically significant visual or cognitive impairment 6. Illiterate 7. Prisoners 8. Women who are pregnant, who plan to become pregnant during the course of the study, or who are breastfeeding 9. Presence of clinically unstable cardiovascular disease 10. Active malignancy treatment

Inclusion Criteria

Exclusion Criteria

1. Age 18 or above
2. Received a kidney transplant within the past year with functioning kidney (eGFR \> 30 mL/min
3. Person with Type 2 Diabetes and on insulin
4. Access to home wi-fi connection

1. Person with Type 1 Diabetes
2. Patients taking hydroxyurea
3. Patient unable to wear the Dexcom G6 device at all times for any reason
4. Must be able to test blood glucose with meter 4x a day when on blinded CGM.
5. Presence of clinically significant visual or cognitive impairment
6. Illiterate
7. Prisoners
8. Women who are pregnant, who plan to become pregnant during the course of the study, or who are breastfeeding
9. Presence of clinically unstable cardiovascular disease
10. Active malignancy treatment

Contacts and Locations

Study Contact

Dahlia Zuidema, PharmD

CONTACT

916-734-4009

dmzuidema@ucdavis.edu

Clinical Research Coordinators

CONTACT

916-734-4009

HS-TransplantCenterResearch@ucdavis.edu

Principal Investigator

Ling Chen, MD

STUDY_DIRECTOR

UCDavis Transplant Nephrology

Study Locations (Sites)

UC Davis Health

Sacramento, California, 95817

United States

Collaborators and Investigators

Sponsor: University of California, Davis

Ling Chen, MD, STUDY_DIRECTOR, UCDavis Transplant Nephrology

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-06-29

Study Completion Date2025-12-31

Study Record Updates

Study Start Date2021-06-29

Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

Kidney Transplant; Complications
Diabetes Mellitus, Type 2
Insulin Dependent Diabetes